Advertisement

Current Medical Science

, Volume 39, Issue 1, pp 52–58 | Cite as

Continuous Positive Airway Pressure Effectively Alleviates Arrhythmias in Patients with Obstructive Sleep Apnea: Possible Relationship with Counteracting Oxidative Stress

  • Xiao-ting Wang
  • Gang ZhaoEmail author
  • Ling Tu
  • Zhi-yong Yue
  • Zhen-hua Liu
  • Jie Han
  • Kun Gao
  • Xuan-chen Zhou
  • Shuai Xu
  • Jian-feng LiEmail author
Article
  • 12 Downloads

Abstract

This work is aimed at exploring the clinical efficacy of continuous positive airway pressure (CPAP) in treatment of patients with arrhythmias combined with obstructive sleep apnea (OSA). Through evaluating serum native thiol, malonaldehyde (MDA) and nicotinamide adenine dinucleotide phosphate oxidase (NADPH oxidase) in these patients and describing the effects on oxidative parameters of CPAP therapy for 3 months, we confirmed the impact of oxidative stress on arrhythmias. A total of 64 patients with OSA combined with arrhythmias were collected from April 2014 to April 2017 with full clinical information. Patients were divided into two groups (paired experiment design): 32 patients in group A (control group), who received unchanged anti-arrhythmia treatment and 32 patients in group B, who were subjected to unchanged pharmacological anti-arrhythmia therapy combined with CPAP. OSA related parameters were compared between the two groups after 3-month therapy. And the levels of parameters of oxidative stress in patients were measured before and after CPAP therapy. After 3 months of CPAP therapy, compared with the control group, the percentage of sage N3 (NREM 3) and stage R (REM) in total sleep time was significantly increased, while apnea-hypopnea index (AHI) and the Epworth Sleepiness Scale (ESS) score were evidently decreased. Meanwhile, the lowest oxygen saturation (LSpO2) was also elevated after CPAP treatment for 3 months. The CPAP therapy significantly prevented the occurrence of arrhythmias (P<0.05). Both the MDA level and NADPH oxidase levels were significantly lower in the group B than in the group A (P<0.05). But serum native thiol was improved by CPAP treatment (P<0.05). In conclusion, proper use of CPAP therapy provides significant benefits for the treatment of arrhythmia in patients with OSA.

Key words

obstructive sleep apnea arrhythmias oxidative stress polysomnography continuous positive airway pressure 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Ozcelik H, Kayar Y, Danalioglu A, et al. Does CPAP treatment lead to gastroesophageal reflux in patients with moderate and severe OSA? Eur Arch Otorhinolaryngol, 2017,274(3):1223–1229CrossRefGoogle Scholar
  2. 2.
    Peppard PE, Young T, Barnet JH, et al. Increased prevalence of sleep–disordered breathing in adults. Am J Epidemiol, 2013,177(9):1006–1014CrossRefGoogle Scholar
  3. 3.
    Agrawal A, Verma I, Shah V, et al. Cardiac manifestations of idiopathic pulmonary fibrosis. Intractable Rare Dis Res, 2016,5(2):70–75CrossRefGoogle Scholar
  4. 4.
    Patel N, Donahue C, Shenoy A, et al. Obstructive sleep apnea and arrhythmia: A systemic review. Int J Cardiol, 2017,228:967–970CrossRefGoogle Scholar
  5. 5.
    Vianello A, Bisogni V, Rinaldo C, et al. Recent advances in the diagnosis and management of obstructive sleep apnea. Minerva Med, 2016,107(6):437–451Google Scholar
  6. 6.
    Mancuso M, Bonanni E, LoGerfo A, et al. Oxidative stress biomarkers in patients with untreated obstructive sleep apnea syndrome. Sleep Med, 2012,13(6):632–636CrossRefGoogle Scholar
  7. 7.
    Yamamoto H, Teramoto S, Yamaguchi Y, et al. Effect of nasal continuous positive airway pressure treatment on plasma adrenomedullin levels in patients with obstructive sleep apnea syndrome: roles of nocturnal hypoxia and oxidant stress. Hypertens Res, 2007,30(11):1065–1076CrossRefGoogle Scholar
  8. 8.
    Jordan W, Cohrs S, Degner D, et al. Evaluation of oxidative stress measurements in obstructive sleep apnea syndrome. J Neural Transm (Vienna), 2006,113(2):239–254CrossRefGoogle Scholar
  9. 9.
    Xu LF, Zhou XF, Hu K, et al. Establishment of a Rabbit Model of Chronic Obstructive Sleep Apnea and Application in Cardiovascular Consequences. Chin Med J (Engl), 2017,130(4):452–459CrossRefGoogle Scholar
  10. 10.
    Carratu P, Zito A, Dragonieri S, et al. Effect of CPAP on cardiovascular risks in OSA patients. A 4–year followup, preliminary data. Sleep Breath, 2017,21(1):143–144CrossRefGoogle Scholar
  11. 11.
    Yu J, Zhou Z, McEvoy RD, et al. Association of Positive Airway Pressure With Cardiovascular Events and Death in Adults With Sleep Apnea: A Systematic Review and Meta–analysis. JAMA, 2017,318(2):156–166CrossRefGoogle Scholar
  12. 12.
    Jackson ML, McEvoy RD, Banks S, et al. Neurobehavioral Impairment and CPAP Treatment Response in Mild–Moderate Obstructive Sleep Apneas. J Clin Sleep Med, 2018,14(1):47–56CrossRefGoogle Scholar
  13. 13.
    Toth B, Auth A, Rompos L, et al. Effect of feed deprivation on selected parameters of lipid mobilisation and hepatic function in healthy Akhal Teke horses. Equine Vet J, 2018,50(1):98–103CrossRefGoogle Scholar
  14. 14.
    Nieuwenhuijsen K, Hulshof CT, Sluiter JK. The influence of risk labeling on risk perception and willingness to seek help in an experimental simulation of preventive medical examinations. Patient Educ Couns, 2018,101(7):1291–1297CrossRefGoogle Scholar
  15. 15.
    Wu MN, Lai CL, Liu CK, et al. Basal sympathetic predominance in periodic limb movements in sleep after continuous positive airway pressure. Sleep Breath, 2018,22(4):1005–1012CrossRefGoogle Scholar
  16. 16.
    Ye L, Qian Y, Li Q, et al. Serum Romo1 is significantly associated with disease severity in patients with obstructive sleep apnea syndrome. Sleep Breath, 2018,22(3):743–748CrossRefGoogle Scholar
  17. 17.
    Drager LF, McEvoy RD, Barbe F, et al. Sleep Apnea and Cardiovascular Disease: Lessons From Recent Trials and Need for Team Science. Circulation, 2017,136(19):1840–1850CrossRefGoogle Scholar
  18. 18.
    Linz D, Linz B, Hohl M, et al. Atrial arrhythmogenesis in obstructive sleep apnea: Therapeutic implications. Sleep Med Rev, 2016,26:87–94CrossRefGoogle Scholar
  19. 19.
    Hong KL, Glover BM. The impact of lifestyle intervention on atrial fibrillation. Curr Opin Cardiol, 2018,33(1):14–19CrossRefGoogle Scholar
  20. 20.
    Mehra R, Benjamin EJ, Shahar E, et al. Association of nocturnal arrhythmias with sleep–disordered breathing: The Sleep Heart Health Study. Am J Respir Crit Care Med, 2006,173(8):910–916CrossRefGoogle Scholar
  21. 21.
    Latshang TD, Kaufmann B, Nussbaumer–Ochsner Y, et al. Patients with Obstructive Sleep Apnea Have Cardiac Repolarization Disturbances when Travelling to Altitude: Randomized, Placebo–Controlled Trial of Acetazolamide. Sleep, 2016,39(9):1631–1637CrossRefGoogle Scholar
  22. 22.
    Sforza E, Roche F. Chronic intermittent hypoxia and obstructive sleep apnea: an experimental and clinical approach. Hypoxia, 2016,4:99–108CrossRefGoogle Scholar
  23. 23.
    Goudis CA, Ketikoglou DG. Obstructive sleep and atrial fibrillation: Pathophysiological mechanisms and therapeutic implications. Int J Cardiol, 2017,230:293–300CrossRefGoogle Scholar
  24. 24.
    Drager LF, McEvoy RD, Barbe F, et al. Sleep Apnea and Cardiovascular Disease: Lessons From Recent Trials and Need for Team Science. Circulation, 2017,136(19):1840–1850CrossRefGoogle Scholar
  25. 25.
    Bagai K. Obstructive sleep apnea, stroke, and cardiovascular diseases. Neurologist, 2010,16(6):329–339CrossRefGoogle Scholar
  26. 26.
    Lin X, Chen G, Qi J, et al. Effect of continuous positive airway pressure on arterial stiffness in patients with obstructive sleep apnea and hypertension: a meta–analysis. Eur Arch Otorhinolaryngol, 2016,273(12):4081–4088CrossRefGoogle Scholar
  27. 27.
    Lira AB, de Sousa Rodrigues CF. Evaluation of oxidative stress markers in obstructive sleep apnea syndrome and additional antioxidant therapy: a review article. Sleep Breath, 2016,20(4):1155–1160CrossRefGoogle Scholar
  28. 28.
    Gul F, Muderris T, Yalciner G, et al. A novel method for evaluation of oxidative stress in children with OSA. Int J Pediatr Otorhinolaryngol, 2016,89:76–80CrossRefGoogle Scholar
  29. 29.
    Hoffmann MS, Singh P, Wolk R, Narkiewicz K, Somers VK. Obstructive sleep apnea and intermittent hypoxia increase expression of dual specificity phosphatase 1. Atherosclerosis, 2013,231(2):378–383CrossRefGoogle Scholar
  30. 30.
    Deering S, Liu L, Zamora T, et al. CPAP Adherence is Associated With Attentional Improvements in a Group of Primarily Male Patients With Moderate to Severe OSA. J Clin Sleep Med, 2017,13(12):1423–1428CrossRefGoogle Scholar
  31. 31.
    Deng G, Qiu ZD, Li DY, et al. Effects of continuous positive airway pressure therapy on plasma aldosterone levels in patients with obstructive sleep apnea: A meta-analysis. J Huazhong Univ Sci Technolog Med Sci, 2016,36(5):619–625CrossRefGoogle Scholar

Copyright information

© Huazhong University of Science and Technology 2019

Authors and Affiliations

  • Xiao-ting Wang
    • 1
    • 2
  • Gang Zhao
    • 3
    Email author
  • Ling Tu
    • 4
  • Zhi-yong Yue
    • 1
  • Zhen-hua Liu
    • 5
  • Jie Han
    • 1
  • Kun Gao
    • 1
  • Xuan-chen Zhou
    • 1
  • Shuai Xu
    • 1
  • Jian-feng Li
    • 1
    • 2
    Email author
  1. 1.Department of Otolaryngology-Head and Neck SurgeryShandong Provincial Hospital Affiliated to Shandong UniversityJinanChina
  2. 2.Shandong Provincial Key Laboratory of OtologyJinanChina
  3. 3.Department of CardiologyShandong Provincial Hospital Affiliated to Shandong UniversityJinanChina
  4. 4.Department of Geriatric Medicine, Tongji Hospital, Tongji Medical CollegeHuazhong University of Science and TechnologyWuhanChina
  5. 5.Sleep Medicine CenterShandong Provincial Hospital Affiliated to Shandong UniversityJinanChina

Personalised recommendations